Icagen Completes Enrollment in Phase II Allergen Challenge Asthma Trial
23 avr. 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 23, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported the completion of enrollment in the Company's Phase II proof-of-concept study of senicapoc in...
Icagen Presents Results of Phase I Program of ICA-105665
17 avr. 2009 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 17, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today presented results of the Company's Phase I program for ICA-105665, the Company's lead drug candidate...
Icagen to Present Results of Phase I Program of ICA-105665
13 avr. 2009 16h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 13, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that results of the Company's Phase I program for ICA-105665, the Company's lead drug...
Icagen Provides Update On ICA-105665
31 mars 2009 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 31, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that it has received notification from the FDA that, based on a review of certain...
Icagen Initiates Study of Senicapoc in Exercise Induced Asthma
11 mars 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 11, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced the initiation of a Phase II proof-of-concept study of senicapoc, a novel orally available...
Icagen Reports Fourth Quarter and Full Year 2008 Financial Results
11 mars 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 11, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the fourth quarter and full year ended...
Icagen to Announce Fourth Quarter and Full Year 2008 Results and Conduct Conference Call On March 11, 2009
27 févr. 2009 07h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release financial results for the fourth quarter and full year 2008 on Wednesday,...
Icagen to Present At the 11th Annual BIO CEO & Investor Conference On February 10, 2009
02 févr. 2009 07h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 11th Annual BIO CEO and Investor Conference...
Icagen to Present At the JP Morgan Healthcare Conference On January 15, 2009
06 janv. 2009 08h00 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 27th Annual JP Morgan Healthcare Conference...
Icagen Adopts Shareholder Rights Plan
03 déc. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 3, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that its Board of Directors has adopted a shareholder rights plan designed to ensure that all...